Skip to content

Effectiveness of the Individualized Metacognitive Training (EMC+) in People With Psychosis of Brief Evolution

Effectiveness of the Individualized Metacognitive Training (EMC+) in People With Psychosis of Brief Evolution

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04429412
Enrollment
70
Registered
2020-06-12
Start date
2015-01-01
Completion date
2018-09-01
Last updated
2020-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brief Psychotic Disorder, Psychosis; Episode

Brief summary

The main aim of the study is to evaluate the effectiveness of Individualized Meta-Cognitive Training (EMC +), in people with psychosis of brief evolution on symptoms, especially on positive symptoms. Secondary aims would be to assess the effect of EMC+ in metacognition, psychosocial and neuropsychological functioning, and to assess the maintenance of program effects on 6 months.

Detailed description

This is a randomized clinical trial in which some patients receive the EMC+ and others treatment as usual.The evaluator will be blind to the group to which the patients belong. The sample for the overall project will be a total of 70 people with a diagnosis of psychotic spectrum, less than 5 years of experience and with a score =\> 3 positive PANSS (last month) and treated in one of the participating institutions. The evaluation was performed at baseline, at post-treatment and at 6 months follow up. Symptoms, metacognition, psychosocial and neuropsychological functioning were assessed. The EMC consists of 10 therapeutic units with weekly sessions of 45-60 minutes. The material available for the Individualized Metacognitive Training (EMC) program is made up of power-point presentations.

Interventions

BEHAVIORALMCT+

Metacognitive training

Sponsors

Parc Sanitari Sant Joan de Déu
CollaboratorOTHER
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
CollaboratorOTHER
Servicio Andaluz Jaén y Málaga
CollaboratorUNKNOWN
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
CollaboratorOTHER
Parc de Salut Mar
CollaboratorOTHER
Centre d'Higiene Mental Les Corts
CollaboratorOTHER
Institut Pere Mata
CollaboratorUNKNOWN
Institut Assistència Sanitària Girona
CollaboratorUNKNOWN
Hospital Clínico Universitario de Valencia
CollaboratorOTHER
Fundació Sant Joan de Déu
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

The evaluator will be blind to the group that owns the patients included.

Intervention model description

This is a randomized clinical trial in which some patients receive the EMC+ and others treatment as usual.

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of : schizophrenia, schizoaffective disorder, brief psychotic disorder, delusional disorder, schizophreniform disorder, psychotic disorder not otherwise specified. * Less than 5 years of evolution. * Score at or above 4 on the PANSS during the last year (delusions, grandiosity, suspiciousness).

Exclusion criteria

* Traumatic brain injury, dementia, or intellectual disability (premorbid IQ ≤70). * Substance dependence. * Score at or above 5 on the PANSS ( Hostility and Uncooperativeness); score at or above 6 on the PANSS (suspiciousness).

Design outcomes

Primary

MeasureTime frameDescription
PANSS. Positive and Negative Syndrome Scale. (Kay et al., 1987; Peralta and Cuesta, 1994)baseline.The Positive and Negative Syndrome Scale (PANSS). This scale measures 30 symptoms on a scale of 1-7, with higher scores indicating greater psychopathology. The PANSS contains three sub-scales: positive, negative and general symptoms. Range: 7-112. Higher values represent a worse outcome.

Secondary

MeasureTime frameDescription
Jumping to conclusions. (Brett-Jones et al. 1987).baselineThree different computer tasks were used in the study. In Task 1, jars contained balls of two different colors; in one of them the proportion was 85 black versus 15 orange balls and in the other the ratio was reversed. Task 2 was the same as Task 1 but with a proportion of 60:40 in each jar. Finally, Task 3 was similar to Task 2 but instead of balls, the jars contained positive or negative comments with a proportion of 60:40. The patients had to decide which to jar belonged the extracted balls or comments. At all times the participants had information about the balls previously extracted, in order to control the effect of memory. The subjects could remove as many balls as needed to make their final decision (Garety et al., 2005). JTC was considered as taking a decision after extracting 1 or 2 balls.Dichotomous: yes/no. A yes represents a worse outcome
BCIS. Beck Cognitive and Insight Scale. (Beck et al., 2004; Gutierrez-Zotes et al., 2012)baselineThe Beck Cognitive Insight Scale. this scale is a self-registering measure of 15 items .which evaluates how the patients assess their own judgement. It has two dimensions; self-reflection (R) (9 items), and self-certainty (C) (6 items). A compound index of cognitive insight is obtained as the subtraction of self-certainty from self-reflection (R-C).Range: 0-45. Higher values represent a better outcome
IPSAQ. Internal, Personal and Situational Attribution Questionnaire. (Kinderman & Bentall, 1996)baselineThe scale assess the attributional style in 32 situations. Personalizing Bias (PB) indicates the proportion of external attributions for negative events which are personal as opposed to situational. A PB score of greater than 0.5 therefore represents a greater tendency to use personal rather than situational external attributions for negative events.
The Hinting Task. (Corcoran et al. 1995; Gil et al. 2012)baselineThe Scale assess Theory of Mind.Possible range: 0-12. Higher values represent a better outcome
Emotional Recognition Test Faces. (Baron-Cohen et al. 1997)baseline20 photographs that express ten basic and ten complex emotions.Possible range: 0-20. Higher values represent a better outcome
MASC. (Lahera et al.2014).immediately after the interventionA Movie for the Assessment of Social Cognition. Spanish Validation. 46 multiple-choice questions about the emotions, thoughts or intentions of the protagonists. Only one answer out of four is correct. The four choices of each answer include, (1) correct attribution of ToM to the characters of the film, (2) excessive ToM errors (a mental state that is attributed when there is no reason to), (3) reduced ToM errors (a present mental state that is not attributed) and (4) total absence of mental inference (a physical causality attribution instead of a mental state). These errors could be classified as overmentalization, undermentalization and absence of mentalization.

Other

MeasureTime frameDescription
SFS. Social Functioning Scale.(Birchwood et al, 1990; Torres y Olivares, 2000).baselineThis scale assess social functioning in people with psychotic disorders. Range: 45-195
WCST(Wisconsin Card Sorting Test, Bergs et al, 1948)baselinemeasure of executive function. Categories completed and perseverative errors. Higher values represent a better outcome.
Test Stroop (Stroop, 1935)baselineflexibility and inhibition of automatic responses.Higher values represent a better outcome.
TMT A B (Trail Making Test, Reitan, 1993)baselinevisual attention and task switching. Higher values represent a worse outcome.
CPT-IP (Continous Performance Test, Matrics)baselinemeasure of attention. Higher values represent a better outcome.
TAVEC (Verbal Learning Test), Benedet and Aleixandre 1998)baselinemeasure of verbal memory.Higher values represent a better outcome.
WAIS-III (Weschler Adults Intelligence Scale, Wechsler 1955)baselinevocabulary subscale. Higher values represent a better outcome.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026